```html

West Syndrome – Comprehensive Medical Guide

Overview

West syndrome is a rare, severe form of infantile epilepsy that typically begins in the first year of life. It is characterized by a specific type of seizure called infantile spasms, a distinctive electroencephalogram (EEG) pattern known as hypsarrhythmia, and a subsequent arrest or regression of developmental milestones.

Although the syndrome can affect any infant, it is most common in babies between 3 and 8 months of age. The condition is slightly more prevalent in males than females.

According to the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH), the overall incidence of West syndrome is about 2–3 cases per 10,000 live births, making it a rare but critical pediatric neurological emergency.

Symptoms

West syndrome presents with a triad of features, but not all children exhibit every component at the same time. The main symptoms include:

• Infantile spasms (salaam attacks) – sudden, brief (1‑5 seconds) flexor or extensor contractions of the neck, trunk, and limbs. Spasms often occur in clusters, especially upon awakening or after feeding.
• Hypsarrhythmia on EEG – a chaotic, high‑voltage pattern with random spikes and slow waves. This pattern is pathognomonic for West syndrome.
• Developmental regression – loss of previously acquired motor, language, or social skills. Parents may notice the child no longer smiles, tracks objects, or babbles as before.
• Altered consciousness – brief periods of staring or “blanking out” that may follow a spasm cluster.
• Feeding difficulties – because spasms can interrupt sucking or cause fatigue.
• Sleep disturbances – spasms tend to cluster during the transition from wakefulness to sleep, leading to fragmented sleep.
• Other seizure types – as the condition evolves, some children develop additional seizure types (e.g., tonic, myoclonic).
• Physical signs of an underlying cause – such as facial dysmorphisms, organomegaly, or skin lesions that may hint at a metabolic or genetic disorder.

Causes and Risk Factors

West syndrome is not a single disease but a syndrome with many possible etiologies. Causes are broadly categorized into three groups:

1. Structural brain abnormalities

• Congenital malformations (e.g., cortical dysplasia, lissencephaly, agenesis of the corpus callosum)
• Acquired lesions (e.g., hypoxic‑ischemic encephalopathy, intracranial hemorrhage, stroke)

2. Metabolic or genetic disorders

• Inborn errors of metabolism (e.g., pyridoxine‑dependent epilepsy, maple‑syndrome, organic acidurias)
• Chromosomal abnormalities (e.g., trisomy 21, 15q11‑q13 duplication)
• Single‑gene mutations (e.g., ARX, CDKL5, STXBP1)
• Familial or sporadic cases with unknown genetic basis

3. Unknown (idiopathic) origin

In roughly 30‑40 % of cases, no identifiable cause is found despite extensive testing; this is termed “cryptogenic” or “idiopathic” West syndrome.

Risk factors that increase the likelihood of developing West syndrome include:

• Prematurity (<37 weeks gestation) – especially extremely preterm infants (<28 weeks)
• Low birth weight
• Perinatal asphyxia or severe neonatal infections (e.g., meningitis)
• Family history of epilepsy or known genetic mutations
• Maternal exposure to certain toxins or infections during pregnancy (e.g., cytomegalovirus)

Diagnosis

Timely diagnosis is essential because early treatment improves developmental outcomes. The diagnostic work‑up typically proceeds as follows:

Clinical evaluation

• Detailed history (onset, frequency, and pattern of spasms; developmental milestones; prenatal and perinatal factors)
• Comprehensive neurologic examination

Electroencephalogram (EEG)

A high‑quality, video‑EEG study is the gold standard. It captures the characteristic hypsarrhythmia pattern and correlates clinical spasms with electrical activity.

Neuroimaging

• MRI of the brain – preferred modality to detect structural lesions, cortical malformations, or post‑ischemic changes.
• CT scan is reserved for emergencies when MRI is unavailable.

Metabolic and genetic testing

• Serum and urine metabolic panels (amino acids, organic acids, lactate, pyruvate)
• Targeted genetic panels or whole‑exome sequencing when a genetic cause is suspected.

Additional assessments

• Vision and hearing screens – many underlying disorders affect sensory pathways.
• Cardiac evaluation if a systemic syndrome is suspected (e.g., tuberous sclerosis).

According to the Mayo Clinic, a definitive diagnosis is usually reached within 2–4 weeks of presentation when these investigations are performed promptly.

Treatment Options

Management aims to stop spasms, normalize the EEG, and preserve neurodevelopmental potential. Treatment is usually initiated by a pediatric neurologist or epileptologist.

First‑line medications

• Adrenocorticotropic hormone (ACTH) – high‑dose regimens (e.g., 150 U/m² per day) for 2–4 weeks, then tapering. ACTH is the most studied therapy and improves long‑term outcomes in many studies (e.g., J Neurol Neurosurg Psychiatry, 2020).
• Vigabatrin – especially effective for West syndrome caused by tuberous sclerosis complex. Dose is typically 50 mg/kg/day divided twice daily.
• Pyridoxine (Vitamin B6) – a trial dose (100 mg IV) is given when a pyridoxine‑dependent epilepsy is suspected.

Second‑line and adjunctive therapies

• Oral corticosteroids (prednisone or prednisolone) for patients who cannot tolerate ACTH.
• Other antiseizure drugs (ASDs) such as topiramate, valproic acid, or levetiracetam – used when spasms persist despite first‑line therapy.
• Ketogenic diet – a high‑fat, low‑carbohydrate diet that can reduce seizure burden, especially in refractory cases.
• Surgical options (e.g., focal cortical resection, corpus callosotomy) – considered when a discrete structural lesion is identified and seizures are drug‑resistant.

Supportive care

• Physical, occupational, and speech therapy to address developmental delays.
• Nutritional support and feeding therapy for infants with poor weight gain.
• Regular ophthalmologic and audiologic assessments.
• Psychosocial support for families (counseling, support groups, and respite care).

Evidence from the CDC and Cleveland Clinic indicates that early, aggressive treatment improves the likelihood of achieving normal or near‑normal development in up to 40‑50 % of children compared with delayed therapy.

Living with West Syndrome

Even with optimal treatment, many children require ongoing multidisciplinary care. Practical tips for families include:

• Establish a seizure diary – record time, duration, triggers, and response to medication.
• Maintain regular follow‑up appointments – at least every 3‑6 months with neurology, plus annual developmental assessments.
• Create a safe environment – use soft bedding, remove sharp objects, and install safety gates to prevent injury during a spasm.
• Promote sleep hygiene – consistent bedtime routine, dim lighting, and a cool sleeping area can reduce nocturnal spasms.
• Encourage interaction – talk, sing, and read to the infant daily to stimulate language and social skills.
• Monitor growth and nutrition – schedule regular pediatric visits to track weight, height, and feeding adequacy.
• Stay educated – attend webinars or workshops offered by epilepsy foundations (e.g., Epilepsy Foundation, International League Against Epilepsy).
• Plan for emergencies – keep rescue medication (e.g., rectal diazepam) on hand if prescribed, and ensure all caregivers know when and how to use it.

Prevention

Because many cases are linked to genetic or unavoidable prenatal events, absolute prevention is not possible. However, risk can be reduced by:

• Ensuring optimal prenatal care – control maternal infections, avoid teratogenic medications, and manage chronic illnesses.
• Preventing perinatal complications – timely treatment of birth asphyxia, avoiding prolonged hypoxia during delivery.
• Screening high‑risk neonates – early EEG in preterm infants or those with known brain injury.
• Genetic counseling – families with a known hereditary mutation can benefit from pre‑conception counseling.
• Vaccinations and infection control – reducing maternal and neonatal infections (e.g., rubella, CMV) that may cause brain injury.

Complications

If left untreated or inadequately controlled, West syndrome can lead to several serious complications:

• Permanent neurodevelopmental impairment – including intellectual disability, cerebral palsy, and autism spectrum disorder.
• Refractory epilepsy – ongoing seizures that persist into childhood and adulthood.
• Growth suppression – prolonged high‑dose steroids or ACTH can affect growth and bone density.
• Vision and hearing loss – especially when underlying metabolic or structural disease involves sensory pathways.
• Medication side effects – vigabatrin may cause visual field defects; ACTH can lead to hypertension, hyperglycemia, and infection risk.
• Psychosocial burden – increased caregiver stress, financial strain, and reduced quality of life for the family.

When to Seek Emergency Care

---

References: Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic, Epilepsy Foundation, Journal of Neurology, Neurosurgery & Psychiatry (2020), and peer‑reviewed genetic studies (2021‑2023).

```